3.
CKD各期的临床特征
Clinical characteristics of individuals at different stages of CKD
| Variables | Total | Stage1 | Stage 2 | Stage 3 | Stage 4 | P |
| CVD: Cardiovascular disease. | ||||||
| Age (year) | 57.0±8.3 | 58.1±8.6 | 62.3±7.8 | 64.8±7.6 | 62.3±9.1 | 0.000 |
| Gender (male:female) | 2303:4987 | 342:902 | 203:1050 | 48:189 | 6:8 | 0.000 |
| History of diabetes (%) | 673(9.2) | 166(13.3) | 252(20.1) | 67 (28.3) | 10(71.4) | 0.000 |
| History of hypertention (%) | 1447(19.8) | 291(23.4) | 409(32.6) | 123(51.9) | 10(71.4) | 0.000 |
| History of CVD (%) | 253(3.5) | 63(5.1) | 83(6.6) | 21(8.9) | 3(21.4) | 0.000 |
| History of dyslipidaemia (%) | 676(9.3) | 129(10.4) | 171(13.6) | 42 (17.7) | 3(21.4) | 0.000 |
| Current Smoker (%) | 1251(17.2) | 190(15.3) | 100 (8.0) | 24 (10.1) | 1(7.1) | 0.000 |
| Diabetes (%) | 1562(21.4) | 366(29.4) | 451(36.0) | 95 (40.1) | 12(85.7) | 0.000 |
| hypertention (%) | 2421(33.2) | 525(42.2) | 631(50.4) | 147(62.0) | 14(100.0) | 0.000 |
| dyslipidaemia (%) | 4770(65.4) | 822(66.1) | 892(71.2) | 187(78.9) | 12(85.7) | 0.000 |
| IGR (%) | 2050(28.1) | 367(29.5) | 327(26.1) | 63 (26.6) | 1(7.1) | 0.173 |
| Central obesity (%) | 5610(77.7) | 991(79.7) | 1102 (87.9) | 206(86.9) | 8(57.1) | 0.000 |
| Obesity (%) | 295(4.0) | 65(5.2) | 66(5.3) | 23(9.7) | 0(0.0) | 0.000 |
| Total cholesterol≥5.18 mmol/L (%) | 1812(24.9) | 251(20.2) | 485(38.7) | 92 (38.8) | 9(64.3) | 0.000 |
| Triacylglycerol≥1.70 mmol/L (%) | 2845(39.0) | 443(35.6) | 618(49.3) | 147(62.0) | 11(78.6) | 0.000 |
| LDL-cholesterol≥3.37 mmol/L (%) | 979 (13.4) | 129(10.4) | 255(20.4) | 53 (22.4) | 5(35.7) | 0.000 |
| HDL-cholesterol < 1.04 mmol/L (%) | 1986(27.2) | 437(35.1) | 212(16.9) | 52 (21.9) | 4(28.6) | 0.000 |